leukemia
Showing NaN - NaN of 151
Leukemia Trial in California City, Chicago, Houston (GDX012, Chemotherapy Agents)
Not yet recruiting
- Leukemia
- GDX012
- Chemotherapy Agents
-
California City, California
- +2 more
May 24, 2023
Leukemia, Lymphoma, Myeloma Trial in Miami, Chicago, San Antonio (LLS Program)
Not yet recruiting
- Leukemia
- +4 more
- LLS Program
-
Miami, Florida
- +2 more
Feb 16, 2023
Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone
Withdrawn
- Drug/Agent Toxicity by Tissue/Organ
- +3 more
- amifostine trihydrate
- +2 more
-
Chicago, Illinois
- +3 more
Jan 31, 2023
Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)
Completed
- Leukemia
- arsenic trioxide
- +4 more
-
Roseville, California
- +191 more
Dec 14, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Blood and Bone Marrow Samples in Chronic Myelogenous Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +3 more
-
San Diego, California
- +160 more
Aug 2, 2022
Blood and Bone Marrow Samples From Previously Untreated Chronic
Completed
- Leukemia
- fluorescence in situ hybridization
- +6 more
-
San Diego, California
- +34 more
Aug 2, 2022
Bone Marrow and Blood Samples in Untreated Acute Myeloid
Completed
- Leukemia
- laboratory biomarker analysis
-
San Diego, California
- +45 more
Aug 2, 2022
Tissue and Blood Samples From Acute Myeloid Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +7 more
-
Mountain View, California
- +76 more
Aug 2, 2022
Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab
Active, not recruiting
- Leukemia
- +2 more
- inotuzumab ozogamicin-dose level 2
- Inotuzumab ozogamicin-dose level 1
-
Los Angeles, California
- +45 more
Mar 9, 2022
Leukemia Trial in Chicago, Kankakee (recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine)
Withdrawn
- Leukemia
- recombinant interferon alfa
- +7 more
-
Chicago, Illinois
- +3 more
Oct 6, 2021
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)
Completed
- Brain and Central Nervous System Tumors
- +10 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021
Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)
Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Leukemia
- Lymphoma
- rituximab
- +7 more
-
Duarte, California
- +24 more
Aug 16, 2021
Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Active, not recruiting
- Leukemia
- +2 more
- laboratory biomarker analysis
-
San Diego, California
- +50 more
Aug 16, 2021
Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Chicago (Fludarabine-Melphalan & Rabbit antithymocyte globulin
Completed
- Leukemia
- +3 more
- Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
- +4 more
-
Chicago, IllinoisThe University of Chicago
Jan 8, 2021
